title: Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.
abstract: Perlecan, a heparan sulfate proteoglycan, is widely distributed in developing and adult tissues and plays multiple, important physiological roles. Studies with knockout mouse models indicate that expression of perlecan and heparan sulfate is critical for proper skeletal morphogenesis. Heparan sulfate chains bind and potentiate the activities of various growth factors such as fibroblast growth factor 2 (FGF-2). Previous studies indicate that important biological activities are associated with the heparan sulfate-bearing domain I of perlecan (PlnDI; French et al. J. Bone Miner. Res. 17 , 48, 2002). In the present study, we have used recombinant, glycosaminoglycan-bearing PlnDI to reconstitute three-dimensional scaffolds of collagen I. Collagen I fibrils bound PlnDI much better than native collagen I monomers or heat-denatured collagen I preparations. Heparitinase digestion demonstrated that recombinant PlnDI was substituted with heparan sulfate and that these heparan sulfate chains were critically important not only for efficient integration of PlnDI into scaffolds, but also for FGF-2 binding and retention. PlnDI-containing collagen I scaffolds to which FGF-2 was bound sustained growth of both MG63, an osteoblastic cell line, and human bone marrow stromal cells (hBMSCs) significantly better than scaffolds lacking either PlnDI or FGF-2. Collectively, these studies demonstrate the utility of PlnDI in creating scaffolds that better mimic natural extracellular matrices and better support key biological activities.
authors.affiliation: Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, USA.
authors.forename: W D
authors.initials: WD
authors.lastname: Yang
authors.forename: R R
authors.initials: RR
authors.lastname: Gomes
authors.forename: M
authors.initials: M
authors.lastname: Alicknavitch
authors.forename: M C
authors.initials: MC
authors.lastname: Farach-Carson
authors.forename: D D
authors.initials: DD
authors.lastname: Carson
mesh_terms: D001854:Bone Marrow Cells / Q000378:metabolism; D002460:Cell Line; D024042:Collagen Type I / Q000378:metabolism*; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D019812:Heparan Sulfate Proteoglycans / Q000737:chemistry* / Q000235:genetics; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D010006:Osteoblasts / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism
chemical_list: D024042:Collagen Type I; D016222:Fibroblast Growth Factor 2; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate; D011994:Recombinant Proteins; C071927:perlecan
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7275-80
references.pmid: 9636139
references.citation: J Surg Res. 2000 Jul;92(1):45-52
references.pmid: 10864481
references.citation: Biomaterials. 1996 Sep;17(18):1819-25
references.pmid: 8879522
references.citation: J Biol Chem. 1996 Apr 26;271(17):10079-86
references.pmid: 8626565
references.citation: Proteomics. 2001 Dec;1(12):1534-41
references.pmid: 11747213
references.citation: Biomaterials. 2000 Mar;21(6):581-93
references.pmid: 10701459
references.citation: Cancer Metastasis Rev. 1996 Jun;15(2):177-86
references.pmid: 8842489
references.citation: Nat Prod Rep. 2002 Jun;19(3):312-31
references.pmid: 12137280
references.citation: Biomaterials. 2003 Aug;24(18):3139-51
references.pmid: 12895587
references.citation: Dev Biol. 1992 Feb;149(2):307-16
references.pmid: 1730387
references.citation: Eur J Biochem. 1997 Jan 15;243(1-2):115-21
references.pmid: 9030729
references.citation: J Biol Chem. 2002 Apr 26;277(17):14657-65
references.pmid: 11847221
references.citation: J Biol Chem. 1991 Dec 5;266(34):22939-47
references.pmid: 1744087
references.citation: J Biol Chem. 1984 Aug 10;259(15):9891-8
references.pmid: 6430905
references.citation: J Bone Miner Res. 2002 Jan;17(1):48-55
references.pmid: 11771669
references.citation: J Cell Biol. 1988 Aug;107(2):743-51
references.pmid: 2971068
references.citation: Thromb Haemost. 1995 Jul;74(1):534-40
references.pmid: 8578521
references.citation: Semin Cell Dev Biol. 2002 Oct;13(5):377-83
references.pmid: 12324220
references.citation: Biomaterials. 2000 Aug;21(16):1689-99
references.pmid: 10905410
references.citation: J Control Release. 2000 Jul 3;67(2-3):141-55
references.pmid: 10825549
references.citation: Tissue Eng. 2003 Feb;9(1):27-36
references.pmid: 12625951
references.citation: J Biol Chem. 2002 Sep 6;277(36):32616-23
references.pmid: 12077148
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2357-62
references.pmid: 12604799
references.citation: Biomaterials. 1999 Jul;20(14):1339-44
references.pmid: 10403052
references.citation: J Cell Biol. 1994 Jun;125(5):1179-88
references.pmid: 8195298
references.citation: J Biol Chem. 1992 Apr 25;267(12):8544-57
references.pmid: 1569102
references.citation: Annu Rev Biochem. 1998;67:609-52
references.pmid: 9759499
references.citation: Tissue Eng. 2000 Apr;6(2):85-103
references.pmid: 10941205
references.citation: J Biol Chem. 2004 Mar 26;279(13):12346-54
references.pmid: 14707131
references.citation: Biomaterials. 2004 Jul;25(16):3233-43
references.pmid: 14980418
references.citation: J Biomed Mater Res. 2002 Nov;62(2):185-94
references.pmid: 12209938
references.citation: Pharm Sci Technolo Today. 2000 Mar;3(3):80-89
references.pmid: 10707043
references.citation: Ann N Y Acad Sci. 2003 May;995:140-50
references.pmid: 12814946
references.citation: J Cell Sci. 2003 May 1;116(Pt 9):1827-35
references.pmid: 12665563
references.citation: Ann N Y Acad Sci. 2002 Jun;961:143-53
references.pmid: 12081884
references.citation: Adv Drug Deliv Rev. 1998 Aug 3;33(1-2):111-139
references.pmid: 10837656
references.citation: Tissue Eng. 2003 Apr;9(2):371-84
references.pmid: 12740100
references.citation: J Cell Biol. 2001 Nov 26;155(5):845-58
references.pmid: 11724824
references.citation: Biochem J. 1996 May 15;316 ( Pt 1):1-11
references.pmid: 8645190
references.citation: J Biol Chem. 1985 Jul 5;260(13):8157-62
references.pmid: 3159726
references.citation: J Biol Chem. 1993 Nov 15;268(32):23906-14
references.pmid: 7693696
references.citation: J Biomed Mater Res. 1999 Jan;44(1):63-72
references.pmid: 10397905
references.citation: Bone. 1996 Nov;19(5):437-45
references.pmid: 8922641
references.citation: J Biomed Mater Res. 2002 Jun 5;60(3):384-91
references.pmid: 11920661
references.citation: APMIS. 2002 May;110(5):355-71
references.pmid: 12076253
references.citation: Biomaterials. 1999 May;20(9):847-58
references.pmid: 10226711
references.citation: J Cell Physiol. 2001 Dec;189(3):266-74
references.pmid: 11748584
references.citation: Biomaterials. 1996 Feb;17(3):291-9
references.pmid: 8745326
references.citation: Mol Cell Biol. 1997 Apr;17(4):1938-46
references.pmid: 9121441
references.citation: Cell. 1994 Dec 16;79(6):1005-13
references.pmid: 7528102
references.citation: Biomaterials. 2002 Dec;23(23):4523-31
references.pmid: 12322972
references.citation: J Biomed Mater Res. 2001;58(4):352-7
references.pmid: 11410892
references.citation: Biomaterials. 2001 Sep;22(17):2359-69
references.pmid: 11511033
references.citation: J Cell Biol. 1999 May 31;145(5):1103-15
references.pmid: 10352025
references.citation: J Biol Chem. 1984 Oct 10;259(19):11763-70
references.pmid: 6237102
references.citation: J Clin Invest. 1998 Oct 15;102(8):1599-608
references.pmid: 9788974
references.citation: Biomaterials. 2003 Nov;24(24):4353-64
references.pmid: 12922148